Global Clinical Nutrition For Cancer Care Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

    Clinical nutrition for cancer care refers to the specialized dietary support and interventions tailored to meet the nutritional needs of cancer patients throughout their treatment journey. It involves the provision of personalized nutrition plans aimed at managing symptoms, optimizing treatment outcomes, and improving the overall quality of life for individuals undergoing cancer therapy.

    Sizing and Forecast
    The clinical nutrition for cancer care market size has grown strongly in recent years. It will grow from $4.67 billion in 2023 to $4.92 billion in 2024 at a compound annual growth rate (CAGR) of 5.5%.  The growth in the historic period can be attributed to raising awareness of nutritional needs, the emergence of precision nutrition approaches, changes in healthcare policy and reimbursement models, surgical interventions for cancer, and growing interest in functional foods, nutraceuticals, and dietary supplements.

    The clinical nutrition for cancer care market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%.  The growth in the forecast period can be attributed to a shift towards personalized medicine and precision nutrition approaches, increasing demand for clinical nutrition interventions to support patients, increasing awareness of the impact of nutrition on cancer treatment outcomes, advancements in cancer treatment, integrating structured clinical nutrition pathways in oncology. Major trends in the forecast period include advances in nutritional biomarker research, technological innovations in nutritional products and delivery systems, increased collaboration between oncologists, ongoing advancements in nutritional science, and continued research and development in nutritional science.

    Order your report now for swift delivery, visit the link:
    https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-cancer-care-global-market-report

    Segmentation & Regional Insights
    The clinical nutrition for cancer care market covered in this report is segmented –
    1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
    2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
    3) By Age Group: Adult, Pediatric
    4) By Sales Channel: Online, Retail, Institutional Sales

    North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
    https://www.thebusinessresearchcompany.com/sample.aspx?id=16017&type=smp

    Major Driver Impacting Market Growth
    The rising prevalence of cancer is expected to propel the growth of the clinical nutrition for cancer care market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the potential to spread to other parts of the body. The rise in cancer cases is attributed to increased life expectancy, making a larger aging population more susceptible to cancer. Clinical nutrition for cancer care is used to provide specialized dietary management and nutritional support tailored to the unique needs of cancer patients, aiming to optimize treatment outcomes. For instance, in February 2024, according to the World Health Organization, a US-based intergovernmental organization, approximately 35 million new cancer cases were predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the clinical nutrition for cancer care market.

    Key Industry Players
    Major companies operating in the clinical nutrition for cancer care market are  Pfizer Inc., Bayer AG, Abbott Nutrition, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Evonik Industries AG, Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun Melsungen AG, Koninklijke DSM N.V., Glanbia plc, Kyowa Kirin Co. Ltd, Nestle Health Science S.A., Danone Nutricia, BioGaia AB, Meiji Holdings Company Ltd., Hormel Health Labs, Victus Inc., Taiho Pharmaceutical Co. Ltd., Global Health Products Inc

    The clinical nutrition for cancer care market report table of contents includes:
    1. Executive Summary

    2. Clinical Nutrition For Cancer Care Market Characteristics

    3. Clinical Nutrition For Cancer Care Market Trends And Strategies

    4. Clinical Nutrition For Cancer Care Market - Macro Economic Scenario

    5. Global Clinical Nutrition For Cancer Care Market Size and Growth

    .
    32. Global Clinical Nutrition For Cancer Care Market Competitive Benchmarking

    33. Global Clinical Nutrition For Cancer Care Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Clinical Nutrition For Cancer Care Market

    35. Clinical Nutrition For Cancer Care Market Future Outlook and Potential Analysis

    36. Appendix


    Explore the trending research reports from TBRC:
    Contact Us:
    The Business Research Company
    Europe: +44 207 1930 708
    Asia: +91 88972 63534
    Americas: +1 315 623 0293
    Email: info@tbrc.info
    Follow Us On:
    LinkedIn: https://in.linkedin.com/company/the-business-research-company
    Twitter: https://twitter.com/tbrc_info
    Facebook: https://www.facebook.com/TheBusinessResearchCompany
    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
    Blog: https://blog.tbrc.info/
    Healthcare Blog: https://healthcareresearchreports.com/
    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Post a Comment

Popular posts from this blog

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Image
  The antiepileptic drugs market size has grown strongly in recent years. It will grow from $17.83 billion in 2025 to $18.74 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to epilepsy prevalence growth, first-generation drug reliance, hospital neurology expansion, seizure disorder awareness, generic drug penetration. The antiepileptic drugs market size is expected to see strong growth in the next few years. It will grow to $22.87 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to treatment-resistant epilepsy management, novel AED approvals, personalized neurology care, pediatric epilepsy diagnosis, long-acting formulations. Major trends in the forecast period include shift toward third-generation AEDs, growing use of combination therapy, expansion of pediatric epilepsy management, increased adoption of long-term seizure control, growth of gene...
Read more

Bradykinesia Market 2026–2030: Factors Driving Growth, Demand, And Revenue Expansion

Image
  The bradykinesia market size has grown rapidly in recent years. It will grow from $3.41 billion in 2025 to $3.88 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to parkinson’s disease prevalence, aging population, levodopa therapy adoption, neurology clinic expansion, symptom-based treatment. The bradykinesia market size is expected to see rapid growth in the next few years. It will grow to $6.38 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to neurological drug innovation, early diagnosis adoption, digital disease monitoring, geriatric care growth, personalized neurology. Major trends in the forecast period include increased use of combination parkinson’s therapies, focus on early-stage disease management, expansion of dopaminergic drug use, growth of personalized neurological care, adoption of long-term symptom control strategies. Cla...
Read more

Global Haptic Virtual Reality (VR) Fitness Suit Market Analysis Highlights Emerging Opportunities And Revenue Forecasts Through 2030

Image
  The haptic virtual reality (vr) fitness suit market size has grown exponentially in recent years. It will grow from $1.6 billion in 2025 to $2.05 billion in 2026 at a compound annual growth rate (CAGR) of 27.7%. The growth in the historic period can be attributed to rising popularity of virtual fitness applications, increasing consumer interest in immersive workouts, growth of wearable fitness technologies, expansion of home-based fitness solutions, improvements in haptic hardware capabilities. The haptic virtual reality (vr) fitness suit market size is expected to see exponential growth in the next few years. It will grow to $5.4 billion in 2030 at a compound annual growth rate (CAGR) of 27.4%. The growth in the forecast period can be attributed to increasing adoption of ai-driven fitness personalization, rising demand for remote and virtual training solutions, expansion of rehabilitation and therapeutic vr applications, growing integration of biometric feedback systems, advan...
Read more